Publications by authors named "Steven Devine"

Claim this Profile
A
Allogeneic Hematopoietic Cell Donor Selection: Contemporary Guidelines from the NMDP/CIBMTR.
Antonio M Jimenez Jimenez, Stephen R Spellman, Ioannis Politikos, Shannon R McCurdy, Steven M Devine

Transplant Cell Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomics of Acute Myeloid Leukemia at Diagnosis and Remission.
Kai Yu, Laura W Dillon, Jesse M Tettero, Gege Gui, Rasha W Al-Ali, Steven M Devine

medRxiv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation.
Stephanie J Lee, Brent Logan, Mary M Horowitz, Jason G Dehn, Joseph Pidala, Steven Devine

J Clin Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: BMT CTN 1702 Trial.
Jason G Dehn, Brent Logan, Stephanie J Lee, Bronwen E Shaw, Steven Devine

Transplant Cell Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CHARM is Prognostic of Geriatric Morbidity and Toxicity after Allogeneic Transplant for Older Adults: BMT CTN 1704 Study.
Andrew S Artz, Brent R Logan, Wael Saber, Nancy Geller, Anna Bellach, Steven M Devine

Blood Adv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurable residual mutated NPM1 before allogeneic transplant for acute myeloid leukemia.
Rasha W Al-Ali, Gege Gui, Niveditha Ravindra, Georgia Andrew, Devdeep Mukherjee, Steven M Devine

Bone Marrow Transplant· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of transplant conditioning, NPM1 mutations, and measurable residual disease in FLT3-ITD acute myeloid leukemia.
Mark J Levis, Mehdi Hamadani, Brent R Logan, Richard J Jones, Anurag K Singh, Steven M Devine

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib added to standard conditioning and as maintenance therapy following autologous hematopoietic stem cell transplantation for relapsed or refractory activated-B-cell type Diffuse Large B-cell lymphoma: primary analysis of the US intergroup double-blind randomized phase III study Alliance A051301/BMT-CTN 1201.
Charalambos Andreadis, Olivia Bobek, Eric D Hsi, Timothy S Fenske, Patrick J Stiff, Steven M Devine

Leuk Lymphoma· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to: Current Activity Trends and Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy - A Report from the CIBMTR, Transplantation and Cellular Therapy, 31:8, August 2025, 505-532; Article Number: JTCT-S-25-00377.
Stephen R Spellman, Ke Xu, Temitope Oloyede, Kwang Woo Ahn, Othman Salim Akhtar, Steven M Devine

Transplant Cell Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Matched Unrelated vs Haploidentical Donor Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide.
Dipenkumar Modi, Yosra M Aljawai, Todd E DeFor, Caitrin Bupp, Monzr M Al Malki, Steven M Devine

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation.
Monzr M Al Malki, Stephanie Bo-Subait, Brent Logan, Janelle Olson, Jianqun Kou, Steven Michael Devine

J Clin Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Up-front alternative donor HCT in severe aplastic anemia: gaps and opportunities to translate evidence into practice.
Neel S Bhatt, Azra Borogovac, Yvonne A Efebera, Anna DeSalvo, Steven M Devine

Blood Adv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Activity Trends and Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy - A Report from the CIBMTR.
Stephen R Spellman, Ke Xu, Temitope Oloyede, Kwang Woo Ahn, Othman Akhtar, Steven M Devine

Transplant Cell Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel composite health assessment risk model for older allogeneic transplant recipients: BMT-CTN 1704.
Mohamed L Sorror, Wael Saber, Brent Logan, Nancy Geller, Anna Bellach, Steven M Devine

Blood Adv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD-mutated AML.
Mark J Levis, Mehdi Hamadani, Brent R Logan, Richard J Jones, Anurag K Singh, Steven M Devine

Blood· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is transplant success linked to donor CMV serostatus?
Steven M Devine

Blood Adv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurable residual FLT3 tyrosine kinase domain mutations before allogeneic transplant for acute myeloid leukemia.
Pranay S Hegde, Georgia Andrew, Gege Gui, Niveditha Ravindra, Devdeep Mukherjee, Steven M Devine

Bone Marrow Transplant· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia.
Gege Gui, Niveditha Ravindra, Pranay S Hegde, Georgia Andrew, Devdeep Mukherjee, Steven M Devine

Bone Marrow Transplant· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: Disparities in Allograft Access in the Era of Post-Transplant Cyclophosphamide-Based Mismatched Unrelated Donor Transplantation.
Brian C Shaffer, Mahasweta Gooptu, Todd DeFor, Stephen R Spellman, Heather E Stefanski, Steven M Devine

J Clin Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia.
Gege Gui, Niveditha Ravindra, Pranay S Hegde, Georgia Andrew, Devdeep Mukherjee, Steven M Devine

Bone Marrow Transplant· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generosity of the Unrelated Stem Cell Transplant Donor: Moving from Hope to Reality While Overcoming Challenges to Deliver the Gift of Life.
Steven M Devine

Transplant Cell Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Representativeness of Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Trial Participants.
Manmeet Kaur, Mary M Horowitz, Adam Mendizabal, Min Chen, Amy Foley, Steven Devine

Transplant Cell Ther· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel machine learning technique further clarifies unrelated donor selection to optimize transplantation outcomes.
Stephen R Spellman, Rodney Sparapani, Martin Maiers, Bronwen E Shaw, Purushottam Laud, Steven M Devine

Blood Adv· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors.
Brian C Shaffer, Mahasweta Gooptu, Todd E DeFor, Martin Maiers, Javier Bolaños-Meade, Steven M Devine

J Clin Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: An Interventional Trial.
Jason G Dehn, Brent Logan, Bronwen E Shaw, Steven Devine, Stefan O Ciurea

medRxiv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis